Abstract
Purpose
Type 2 diabetes mellitus (diabetes) is a common comorbid condition among older adult colorectal cancer (CRC) patients, yet its effects on CRC mortality have not been adequately examined. This study aims to investigate the association between pre-existing diabetes, with and without complications, and CRC mortality.
Methods
Medicare beneficiaries 67 years and older diagnosed with CRC between 2002 and 2011 were studied using the Surveillance, Epidemiology, and End Results (SEER)-Medicare datasets. Pre-existing diabetes was ascertained using validated algorithms. Cox proportional hazards models were used to compare all-cause and CRC-cause-specific death risk differences in relation to prior diabetes diagnosis and diabetes severity (with and without complications) with adjustment for relevant patient demographics and disease characteristics.
Results
Analyses included 93,710 CRC patients. Among the study population, 22,155 (24%) had diabetes prior to CRC diagnosis and 4% had diabetes-related complications (neuropathy, nephropathy, retinopathy, or peripheral circulatory disorders). All-cause CRC mortality was significantly higher among diabetic patients compared with non-diabetic patients (hazard ratio (HR) = 1.20; 95% confidence interval (CI) = 1.17–1.23). The results were more pronounced for diabetes with complications (HR = 1.47; 95% CI = 1.34–1.54). Diabetic patients with complications were 16% more likely to die of colorectal cancer compared with patients without diabetes (HR = 1.16; 95% CI = 1.08–1.25).
Conclusion
Pre-existing diabetes contributes to poorer all-cause mortality among CRC patients and increased mortality from CRC among those with diabetes and complications. Opportunities exist to incorporate diabetes prevention and management interventions during CRC treatment phases among older adults.
Similar content being viewed by others
References
Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF (2010) Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metrics 8(1):29. https://doi.org/10.1186/1478-7954-8-29
Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67(1):7–30. https://doi.org/10.3322/caac.21395
Calonge N, Petitti DB, DeWitt TG, Dietrich AJ, Gregory KD, Harris R et al (2008) Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 149(9):627–637. https://doi.org/10.7326/0003-4819-149-9-200811040-00243
Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Aunola S, Cepaitis Z, Moltchanov V, Hakumäki M, Mannelin M, Martikkala V, Sundvall J, Uusitupa M (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344(18):1343–1350. https://doi.org/10.1056/NEJM200105033441801
Harriss DJ, Atkinson G, Batterham A, George K, Tim Cable N, Reilly T, Haboubi N, Renehan AG, The Colorectal Cancer, Lifestyle, Exercise And Research Group (2009) Lifestyle factors and colorectal cancer risk (2): a systematic review and meta-analysis of associations with leisure-time physical activity. Color Dis 11(7):689–701. https://doi.org/10.1111/j.1463-1318.2009.01767.x
Reis JP, Loria CM, Sorlie PD, Park Y, Hollenbeck A, Schatzkin A (2011) Lifestyle factors and risk for new-onset diabetes: a population-based cohort study. Ann Intern Med 155(5):292–299. https://doi.org/10.7326/0003-4819-155-5-201109060-00006
Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, Huang ES, Korytkowski MT, Munshi MN, Odegard PS, Pratley RE, Swift CS (2012) Diabetes in older adults. Diabetes Care 35(12):2650–2664. https://doi.org/10.2337/dc12-1801
Campbell PT, Deka A, Jacobs EJ, Newton CC, Hildebrand JS, McCullough ML et al (2010) Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men. Gastroenterology 139(4):1138–1146. https://doi.org/10.1053/j.gastro.2010.06.072
Deng L, Gui Z, Zhao L, Wang J, Shen L (2012) Diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis. Dig Dis Sci 57(6):1576–1585. https://doi.org/10.1007/s10620-012-2055-1
Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159(12):1160–1167. https://doi.org/10.1093/aje/kwh161
Chiao EY, Nambi PV, Naik AD (2010) The impact of diabetes process and outcome quality measures on overall survival in patients with co-morbid colorectal cancer. J Cancer Surviv 4(4):381–387. https://doi.org/10.1007/s11764-010-0141-y
Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF (2002) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40(8):18 https://www.jstor.org/stable/3767919. Accessed 1 Jan 2019
Research Data (1973–2010) National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2013, based on the November 2012 submission. [Internet].; 2013 [cited July 2013]. Available from: www.seer.cancer.gov
SEER-Medicare: how the SEER and Medicare data are linked [Internet].; 2018 [cited January 1, 2019]. Available from: https://healthcaredelivery.cancer.gov/seermedicare/overview/linked.html. Accessed 1 Jan 2019
Yang Y, Mauldin PD, Ebeling M, Hulsey TC, Liu B, Thomas MB, Camp ER, Esnaola NF (2013) Effect of metabolic syndrome and its components on recurrence and survival in colon cancer patients. Cancer 119(8):1512–1520. https://doi.org/10.1002/cncr.27923
Hebert PL, Geiss LS, Tierney EF, Engelgau MM, Yawn BP, McBean AM (1999) Identifying persons with diabetes using Medicare claims data. Am J Med Qual 14(6):270–277. https://doi.org/10.1177/106286069901400607
Coker AL, Du XL, Fang S, Eggleston KS (2006) Socioeconomic status and cervical cancer survival among older women: findings from the SEER–Medicare linked data cohorts. Gynecol Oncol 102(2):278–284. https://doi.org/10.1016/j.ygyno.2005.12.016
Klabunde CN, Legler JM, Warren JL, Baldwin L, Schrag D (2007) A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol 17(8):584–590. https://doi.org/10.1016/j.annepidem.2007.03.011
Hess KR (1995) Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. Stat Med 14(15):1707–1723
van de Poll-Franse, Lonneke V, Houterman S, Janssen-Heijnen ML, Dercksen MW, Coebergh JWW, Haak HR (2007) Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer 120(9):1986–1992. https://doi.org/10.1002/ijc.22532
Gross CP, Guo Z, McAvay GJ, Allore HG, Young M, Tinetti ME (2006) Multimorbidity and survival in older persons with colorectal cancer. J Am Geriatr Soc 54(12):1898–1904. https://doi.org/10.1111/j.1532-5415.2006.00973.x
Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB III, Fuchs CS (2003) Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol 21(3):433–440. https://doi.org/10.1200/JCO.2003.07.125
Jullumstr E, Kollind M, Lydersen S, Edna T (2009) Diabetes mellitus and outcomes of colorectal cancer. Acta Oncol 48(3):361–367. https://doi.org/10.1080/02841860802637765
Huang Y, Lin J, Chen W, Lin T, Yang S, Jiang J et al (2011) Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease. J Cancer Res Clin Oncol 137(2):211–220. https://doi.org/10.1007/s00432-010-0879-7
Bella F, Minicozzi P, Giacomin A, Crocetti E, Federico M, De Leon MP et al (2013) Impact of diabetes on overall and cancer-specific mortality in colorectal cancer patients. J Cancer Res Clin Oncol 139(8):1303–1310. https://doi.org/10.1007/s00432-013-1439-8
Polednak AP (2006) Comorbid diabetes mellitus and risk of death after diagnosis of colorectal cancer: a population-based study. Cancer Detect Prev 30(5):466–472. https://doi.org/10.1016/j.cdp.2006.07.003
Dehal AN, Newton CC, Jacobs EJ, Patel AV, Gapstur SM, Campbell PT (2011) Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort. J Clin Oncol 30(1):53–59. https://doi.org/10.1200/JCO.2011.38.0303
Feng J, Zhou X, Mao W (2011) Prognostic analysis of colorectal cancer patients with diabetes mellitus in China–the experience of a single institution. Adv Clin Exp Med 20:473–480
Bao Y, Nimptsch K, Meyerhardt JA, Chan AT, Ng K, Michaud DS, Brand-Miller JC, Willett WC, Giovannucci E, Fuchs CS (2010) Dietary insulin load, dietary insulin index, and colorectal cancer. Cancer Epidemiol Biomarkers Prev 19(12):3020–3026. https://doi.org/10.1158/1055-9965.EPI-10-0833
Barone BB, Yeh H, Snyder CF, Peairs KS, Stein KB, Derr RL, Wolff AC, Brancati FL (2008) Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 300(23):2754–2764. https://doi.org/10.1001/jama.2008.824
Stein KB, Snyder CF, Barone BB, Yeh H, Peairs KS, Derr RL et al (2010) Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis. Dig Dis Sci 55(7):1839–1851. https://doi.org/10.1007/s10620-009-0944-8
Huang Y, Lin J, Chen W, Lin T, Yang S, Jiang J et al (2011) Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease. J Cancer Res Clin Oncol 137(2):211–220. https://doi.org/10.1007/s10620-009-0944-8
Mills KT, Bellows CF, Hoffman AE, Kelly TN, Gagliardi G (2013) Diabetes and colorectal cancer prognosis: a meta-analysis. Dis Colon Rectum 56(11):1304–1319. https://doi.org/10.1097/DCR.0b013e3182a479f9
Tsai C, Giovannucci EL (2012) Hyperinsulinemia, insulin resistance, vitamin d, and colorectal cancer among whites and African Americans. Dig Dis Sci 57(10):2497–2503. https://doi.org/10.1007/s10620-012-2198-0
Giovannucci E (2007) Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr 86(3):842S–842S. https://doi.org/10.1093/ajcn/86.3.836S
Luo R, Giordano SH, Freeman JL, Zhang D, Goodwin JS (2006) Referral to medical oncology: a crucial step in the treatment of older patients with stage III colon cancer. Oncologist 11(9):1025–1033. https://doi.org/10.1634/theoncologist.11-9-102539
Gross CP, McAvay GJ, Guo Z, Tinetti ME (2007) The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer. Cancer 109(12):2410–2419 10.1002/cncr.22726
Bradley CJ, Given CW, Dahman B, Fitzgerald TL (2008) Adjuvant chemotherapy after resection in elderly Medicare and Medicaid patients with colon cancer. Arch Intern Med 168(5):521–529. https://doi.org/10.1001/archinternmed.2007.82
O’Grady MA, Slater E, Sigurdson ER, Meropol NJ, Weinstein A, Lusch CJ, Sein E, Keeley P, Miller B, Engstrom PF, Cohen SJ (2011) Assessing compliance with national comprehensive cancer network guidelines for elderly patients with stage III colon cancer: the Fox Chase Cancer Center Partners’ initiative. Clin Colorectal Cancer 10(2):113–116. https://doi.org/10.1016/j.clcc.2011.03.007
Stratton IM, Cull CA, Adler AI, Matthews DR, Neil H, Holman RR (2006) Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia 49(8):1761–1769. https://doi.org/10.1007/s00125-006-0297-1
Irizarry L, Li QE, Duncan I, Thurston AL, Fitzner KA, Edwards BJ, McKoy-Bent JM, Tulas KM, McKoy JM (2013) Effects of cancer comorbidity on disease management: making the case for diabetes education (a report from the SOAR program). Popul Health Manag 16(1):53–57. https://doi.org/10.1089/pop.2012.0028
Smith M, Towne S, Herrera-Venson A, Cameron K, Horel S, Ory M, Gilchrist C, Schneider E, DiCocco C, Skowronski S (2018) Delivery of fall prevention interventions for at-risk older adults in rural areas: findings from a national dissemination. Int J Environ Res Public Health 15(12):2798. https://doi.org/10.3390/ijerph15122798
Ory MG, Smith ML, Patton K, Lorig K, Zenker W, Whitelaw N (2013) Self-management at the tipping point: reaching 100,000 Americans with evidence-based programs. J Am Geriatr Soc 61(5):821–823. https://doi.org/10.1111/jgs.12239
Ory MG, Ahn S, Jiang L, Smith ML, Ritter PL, Whitelaw N, Lorig K (2013) Successes of a national study of the chronic disease self-management program: meeting the triple aim of health care reform. Med Care 51(11):992–998
Ory MG, Ahn S, Jiang L, Lorig K, Ritter P, Laurent DD, Whitelaw N, Smith ML (2013) National study of chronic disease self-management: six-month outcome findings. J Aging Health 25(7):1258–1274. https://doi.org/10.1177/0898264313502531
Ahn S, Basu R, Smith ML, Jiang L, Lorig K, Whitelaw N, Ory MG (2013) The impact of chronic disease self-management programs: healthcare savings through a community-based intervention. BMC Public Health 13(1):1141. https://doi.org/10.1186/1471-2458-13-1141
Mills KT, Bellows CF, Hoffman AE, Kelly TN, Gagliardi G (2013) Diabetes mellitus and colorectal cancer prognosis: a meta-analysis. Dis Colon Rectum 56(11):1304–1319. https://doi.org/10.1097/DCR.0b013e3182a479f9
Acknowledgments
We thank Sani H. Kizilbash, MBBS, MPH for his counseling on data methods and statistical programs.
Funding
This work was partially supported by Exito!- the National Cancer Institute (grant no. 1R25CA134301-01A2).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Human and animal rights and informed consent
The study did not involve research on human subjects and it did not require informed consent.
Conflict of interest
The authors declare that they have no conflict of interest.
Disclaimer
The funding source had no involvement in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
El brahimi, S., Smith, M.L. & Pinheiro, P.S. Role of pre-existing type 2 diabetes in colorectal cancer survival among older Americans: a SEER-Medicare population-based study 2002–2011. Int J Colorectal Dis 34, 1467–1475 (2019). https://doi.org/10.1007/s00384-019-03345-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-019-03345-8